SPY302.97-0.56 -0.18%
DIA254.35-1.42 -0.56%
IXIC9,368.99-43.37 -0.46%

UPDATE: Morgan Stanley Reinstates Abbvie With Overweight, $95 Target Notes 'We view Humira erosion fears as overly discounted and Abbvie's prospects as underappreciated'

Benzinga · 05/11/2020 15:45